Search LIN
LINDE PLC
Nasdaq · CIK 1707925
Last close479.48
Daily change+10.03 (2.14%)
10 Years gain+332.54%
Dividends TTM6.3 (+6.96%)
Dividend yield1.34%
Fundamental Analysis
LIN · STANDARD
SIC 2810 · Industrial Inorganic Chemicals · Fiscal year end 1231
Fundamental
50.5Momentum
57.9Acceleration
57.9Confidence
86.0Annual Revenue10
Quarterly Revenue39
Annual CFO6
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth9.6 / 25
Quality23.8 / 25
Capital Efficiency11.4 / 20
Balance Sheet3.4 / 15
Shareholder Economics0.0 / 10
Forward Indicators2.2 / 5
Signals
Gross margin expansionGross margin improved by 1.5619 percentage points.
Operating leverageOperating margin improved by 1.576 percentage points.
Share count reductionDiluted share count declined 2.4648%.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Key Metrics
Revenue Growth TTM7.14%OK
Revenue CAGR 3Y0.62%OK
Gross Margin38.13%OK
Operating Margin27.61%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC14.02%OK
Incremental Operating Margin 3Y737.43%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-2.46%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $33.99B | $12.50B | $8.92B | $10.35B | $5.09B | 36.79% | 26.25% | 14.97% | 13.26% | 472.2M |
| 2025 FY Dec 31, 2024 | $33.01B | $12.12B | $8.64B | $9.42B | $4.93B | 36.73% | 26.16% | 14.93% | 13.59% | 482.09M |
| 2025 FY Dec 31, 2023 | $32.85B | $11.47B | $8.02B | $9.31B | $5.52B | 34.9% | 24.42% | 16.8% | 12.92% | 492.29M |
| 2024 FY Dec 31, 2022 | $33.36B | $8.62B | $5.37B | $8.86B | $5.69B | 25.83% | 16.09% | 17.06% | 8.26% | 504.04M |
| 2023 FY Dec 31, 2021 | $30.79B | $8.32B | $4.98B | $9.73B | $6.64B | 27.01% | 16.19% | 21.56% | 7.11% | 521.88M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $35.18B | sum latest 4 fiscal quarters Revenue | OK | 0001628280-26-051289, 0001628280-25-047710 |
| Revenue Growth TTM | 7.14% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001628280-26-051289, 0001628280-25-047710 |
| Revenue CAGR 3Y | 0.62% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001628280-26-011430 |
| Revenue CAGR 5Y | 4.52% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001628280-26-011430 |
| Gross Profit CAGR 3Y | 13.2% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001628280-26-011430 |
| Operating Income Growth | 13.63% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001628280-26-051289, 0001628280-25-047710 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 38.13% | Gross Profit / Revenue | OK | 0001628280-26-051289, 0001628280-25-047710 |
| Operating Margin | 27.61% | Operating Income / Revenue | OK | 0001628280-26-051289, 0001628280-25-047710 |
| ROIC | 14.02% | NOPAT / Average Invested Capital | OK | 0001628280-26-051289, 0001628280-25-047710 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001628280-26-051289 |
| Current Ratio | 0.88x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.21x | (Cash + Short-term Investments) / Total Debt | OK | 0001628280-26-051289 |
| Revenue per Diluted Share | $75.73 | Revenue / Diluted Shares | OK | 0001628280-26-051289, 0001628280-25-047710 |